Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00404001 | Study of Oral MD-0727 Administered to Patients With Primary Hypercholesterolemia | PHASE2 | COMPLETED | 150 | — | — | Nov 1, 2006 | Jul 1, 2007 | Oct 1, 2007 | 20 | United States |
| Name | Type | Description |
|---|---|---|
| MD-0727 | DRUG | - |
Inclusion Criteria: * Patient is male or non-pregnant, non-breastfeeding female, at least 18 years of age * Patient must agree to use contraception and/or birth control if sexually active * Patient may not be on lipid-lowering therapies at least 6 weeks prior to study and must have a fasting LDL-C ...